Invictus Medical, a manufacturer of medical devices for the improvement of healthy development for newborns, has received a grant from the National Science Foundation (NSF) Phase II grant to further develop its noise attenuation technology.

"This noise attenuation technology is so important for infants in the NICU. The literature indicates that levels of noise found in these care areas can have short- and long-term health consequences," said George Hutchinson, Invictus Medical's Chief Technology Officer. "The American Academy of Pediatrics' guidelines are very rigorous. This technology actively attenuates noise in incubators while allowing the parents to still converse with their babies. This is so important for language skill development."

The grant gives a total of $735,000 to assist Invictus in completing the development of the noise attenuation technology, which is expected to be completed in 2018. "The impact this product is going to have on the health of preterm infants in the NICU and on their cognitive development is very important," said Dennis Kane, Invictus Medical's CEO. "Invictus is committed to help this vulnerable population and we're gratified that the NSF saw the potential this represents."